RESEARCH
The research in the Liu lab leverages cancer elements to develop new drugs for the treatment of neurological disorders and mental illnesses.
Our research program has led to four patented products, such as tumor suppressor microRNAs (miR-122, miR-125b) and FDA-approved kinase inhibitors (dasatinib, abemaciclib), to treat traumatic brain injury (TBI), post-traumatic stress disorder (PTSD), and other disorders.
project content…?
project content…?
project content…?